← Leaderboards
Arthur G Roberts
University Of Georgia
$2,202,377
Attributed
$2,202,377
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $403.5K · FY2014–21$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,202,377 · 2
By mechanism
R01$1,861,010 · 1
R15$341,367 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Development”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$409,188,846
- Lawrence Corey · Fred Hutchinson Cancer Center$302,964,844
- Wafaa M. El-Sadr · Columbia University Health Sciences$291,216,450
- Constance Ann Benson · University Of California, San Diego$284,817,600
Research focus
Drug DevelopmentInnovationMediatingTransport ProcessAtp HydrolysisLeadFunctional GroupLocationPlaySidePropertyBasePharmaceutical PreparationsMulti-Drug ResistanceBinding SitesExtracellularDrug EffluxBindingDrug InteractionsDrug DesignDrug EfficacyDrug ResistanceCancer TherapyCancerous
Grant awards (7)
Overcoming Cancer Resistance Mediated by the Human MDR1 Transporter$350,605
R01 · FY2021 · CA · contact PI
Overcoming Cancer Resistance Mediated by the Human MDR1 Transporter$403,523
R01 · FY2020 · CA · contact PI
Overcoming Cancer Resistance Mediated by the Human MDR1 Transporter$340,129
R01 · FY2019 · CA · contact PI
Overcoming Cancer Resistance Mediated by the Human MDR1 Transporter$52,895
R01 · FY2019 · CA · contact PI
Overcoming Cancer Resistance Mediated by the Human MDR1 Transporter$350,669
R01 · FY2018 · CA · contact PI
Overcoming Cancer Resistance Mediated by the Human MDR1 Transporter$363,189
R01 · FY2017 · CA · contact PI
THE STRUCTURAL BASIS OF AGONIST TRANSPORT BY THE MULTIPLE DRUG RESISTANCE TRANSPO$341,367
R15 · FY2014 · GM · contact PI